These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 422730)

  • 1. Neuropsychological impairment with schizophrenia vs. acute and chronic cerebral lesions.
    Heaton RK; Vogt AT; Hoehn MM; Lewis JA; Crowley TJ; Stallings MA
    J Clin Psychol; 1979 Jan; 35(1):46-53. PubMed ID: 422730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The schizophrenia-organicity (SC-O) and psychiatric-organic (P-O) MMPI scales: a review.
    Watson CG
    J Clin Psychol; 1984 Jul; 40(4):1008-23. PubMed ID: 6480835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative efficacy of the Sc-O, P-O, P-N, and Sc MMPI scales in differentiating brain-damaged, brain-damaged schizophrenic, schizophrenic, and somatoform disorders in an outpatient setting.
    Puente AE; Rodenbough J; Horton AM
    J Clin Psychol; 1989 Jan; 45(1):99-105. PubMed ID: 2925890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schizophrenia, conduct disorder and depressive disorder: neuropsychological, speech sample and EEG results.
    Selin CL; Gottschalk LA
    Percept Mot Skills; 1983 Oct; 57(2):427-44. PubMed ID: 6634324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychological test performances of paranoid schizophrenic and brain-damaged patients.
    Lewis RF; Nelson RW; Eggertsen C
    J Clin Psychol; 1979 Jan; 35(1):54-9. PubMed ID: 422731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discrimination of schizophrenics with and without nervous system damage using the Luria-Nebraska Neuropsychological Battery.
    Puente AE; Heidelberg-Sanders C; Lund NL
    Int J Neurosci; 1982 Feb; 16(1):59-62. PubMed ID: 7169277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of brain-damage in schizophrenics as measured by the Whitaker Index of Schizophrenic Thinking and the Luria-Nebraska Neuropsychological Battery.
    Puente AE; Heidelberg-Sanders C; Lund N
    Percept Mot Skills; 1982 Apr; 54(2):495-9. PubMed ID: 7079075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychological testing in neurological disorders.
    Smith A
    Adv Neurol; 1975; 7():49-110. PubMed ID: 123114
    [No Abstract]   [Full Text] [Related]  

  • 9. Neuropsychological assessment of schizophrenia versus brain damage: a review.
    Malec J
    J Nerv Ment Dis; 1978 Jul; 166(7):507-16. PubMed ID: 670959
    [No Abstract]   [Full Text] [Related]  

  • 10. Validation of a brain-damage vs. schizophrenia MMPI key.
    Russell EW
    J Clin Psychol; 1975 Oct; 31(4):659-61. PubMed ID: 1194419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative utility of three indices of neuropsychological impairment in a young, chronic schizophrenic population.
    Boucher ML; Dewan MJ; Donnelly MP; Pandurangi AK; Bartell K; Diamond T; Major LF
    J Nerv Ment Dis; 1986 Jan; 174(1):44-6. PubMed ID: 3941309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Watson-Thomas rules for MMPI diagnosis.
    Norton JC; Romano PO
    Dis Nerv Syst; 1977 Oct; 38(10):773-5. PubMed ID: 908243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropsychological impairment in first-episode and chronic schizophrenic patients.
    Albus M; Hubmann W; Ehrenberg C; Forcht U; Mohr F; Sobizack N; Wahlheim C; Hecht S
    Eur Arch Psychiatry Clin Neurosci; 1996; 246(5):249-55. PubMed ID: 8863003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MMPI indices in the discrimination of brain-damaged and schizophrenic groups.
    Holland TR; Lowenfeld J; Wadsworth HM
    J Consult Clin Psychol; 1975 Jun; 43(3):426. PubMed ID: 1159133
    [No Abstract]   [Full Text] [Related]  

  • 15. Cerebral ventricular size and neuropsychological impairment in young chronic schizophrenics. Measurement by the standardized Luria-Nebraska Neuropsychological Battery.
    Golden CJ; Moses JA; Zelazowski R; Graber B; Zatz LM; Horvath TB; Berger PA
    Arch Gen Psychiatry; 1980 Jun; 37(6):619-23. PubMed ID: 6966917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Empirical evaluation of diagnostic rules for evaluation of Luria-Nebraska Neuropsychological Battery profiles of chronic schizophrenic, schizoaffective, and brain-damaged patients.
    Moses JA; Thompson LL; Cardellino JP; Johnson GL
    Int J Neurosci; 1983 Oct; 21(1-2):119-27. PubMed ID: 6671867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardization of the Whitaker Index of Schizophrenic Thinking (WIST) in a Mexican population: a multivariable study.
    Ornelas Bolado AL; Whitaker LC
    J Clin Psychol; 1990 Mar; 46(2):140-7. PubMed ID: 2324297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schizophrenic dementia. Clinical and computed axial tomography correlates.
    Lawson WB; Waldman IN; Weinberger DR
    J Nerv Ment Dis; 1988 Apr; 176(4):207-12. PubMed ID: 3351499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MMPI-WAIS relationships in organic and schizophrenic patients.
    Watson CG; Davis WE; McDermott MT
    J Clin Psychol; 1976 Jul; 32(3):539-40. PubMed ID: 956406
    [No Abstract]   [Full Text] [Related]  

  • 20. Level versus pattern of neuropsychological performance among schizophrenic and diffusely brain-damaged patients.
    Chelune GJ; Heaton RK; Lehman RA; Robinson A
    J Consult Clin Psychol; 1979 Feb; 47(1):155-63. PubMed ID: 429648
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.